{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:03:19Z","timestamp":1791046999087,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T00:00:00Z","timestamp":1497052800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s10549-017-4331-4","type":"journal-article","created":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T12:41:08Z","timestamp":1497098468000},"page":"311-320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Survival improvement in hormone-responsive young breast cancer patients with endocrine therapy"],"prefix":"10.1007","volume":"165","author":[{"given":"Tae In","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ui-Kang","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eui Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SaeByul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyun","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Seok","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Ho","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei Hyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4509-953X","authenticated-orcid":false,"given":"Hee Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,10]]},"reference":[{"key":"4331_CR1","doi-asserted-by":"publisher","first-page":"e7695","DOI":"10.1371\/journal.pone.0007695","volume":"4","author":"H Fredholm","year":"2009","unstructured":"Fredholm H, Eaker S, Frisell J, Holmberg L, Fredriksson I, Lindman H (2009) Breast cancer in young women: poor survival despite intensive treatment. PLoS ONE 4:e7695. doi:\n                        10.1371\/journal.pone.0007695","journal-title":"PLoS ONE"},{"key":"4331_CR2","doi-asserted-by":"publisher","first-page":"e0165409","DOI":"10.1371\/journal.pone.0165409","volume":"11","author":"HL Chen","year":"2016","unstructured":"Chen HL, Zhou MQ, Tian W, Meng KX, He HF (2016) Effect of age on breast cancer patient prognoses: a population-based study using the SEER 18 database. PLoS ONE 11:e0165409. doi:\n                        10.1371\/journal.pone.0165409","journal-title":"PLoS ONE"},{"key":"4331_CR3","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1634\/theoncologist.2014-0290","volume":"20","author":"PG Sivasubramaniam","year":"2015","unstructured":"Sivasubramaniam PG, Zhang BL, Zhang Q, Smith JS, Zhang B, Tang ZH, Chen GJ, Xie XM, Xu XZ, Yang HJ, He JJ, Li H, Li JY, Fan JH, Qiao YL (2015) Breast cancer disparities: a multicenter comparison of tumor diagnosis, characteristics, and surgical treatment in China and the U.S. Oncologist 20:1044\u20131050. doi:\n                        10.1634\/theoncologist.2014-0290","journal-title":"Oncologist"},{"key":"4331_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4048\/jbc.2014.17.4.301","volume":"17","author":"HB Lee","year":"2014","unstructured":"Lee HB, Han W (2014) Unique features of young age breast cancer and its management. J Breast Cancer 17:301\u2013307. doi:\n                        10.4048\/jbc.2014.17.4.301","journal-title":"J Breast Cancer"},{"key":"4331_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10549-014-3125-1","volume":"147","author":"W Sheridan","year":"2014","unstructured":"Sheridan W, Scott T, Caroline S, Yvonne Z, Vanessa B, David V, Karen G, Stephen C (2014) Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time? Breast Cancer Res Treat 147:617\u2013629. doi:\n                        10.1007\/s10549-014-3125-1","journal-title":"Breast Cancer Res Treat"},{"key":"4331_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10549-016-3984-8","volume":"160","author":"A Kataoka","year":"2016","unstructured":"Kataoka A, Iwamoto T, Tokunaga E, Tomotaki A, Kumamaru H, Miyata H, Niikura N, Kawai M, Anan K, Hayashi N, Masuda S, Tsugawa K, Aogi K, Ishida T, Masuoka H, Iijima K, Kinoshita T, Nakamura S, Tokuda Y (2016) Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry. Breast Cancer Res Treat 160:163\u2013172. doi:\n                        10.1007\/s10549-016-3984-8","journal-title":"Breast Cancer Res Treat"},{"key":"4331_CR7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/jnci\/91.11.943","volume":"91","author":"J Peto","year":"1999","unstructured":"Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943\u2013949","journal-title":"J Natl Cancer Inst"},{"key":"4331_CR8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P","volume":"88","author":"KE Malone","year":"2000","unstructured":"Malone KE, Daling JR, Neal C, Suter NM, O\u2019Brien C, Cushing-Haugen K, Jonasdottir TJ, Thompson JD, Ostrander EA (2000) Frequency of BRCA1\/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer 88:1393\u20131402","journal-title":"Cancer"},{"key":"4331_CR9","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1200\/JCO.2007.14.2471","volume":"26","author":"CK Anders","year":"2008","unstructured":"Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Blackwell KL (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26:3324\u20133330. doi:\n                        10.1200\/JCO.2007.14.2471","journal-title":"J Clin Oncol"},{"key":"4331_CR10","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s10549-011-1872-9","volume":"131","author":"LC Collins","year":"2012","unstructured":"Collins LC, Marotti JD, Gelber S, Cole K, Ruddy K, Kereakoglow S, Brachtel EF, Schapira L, Come SE, Winer EP, Partridge AH (2012) Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat 131:1061\u20131066. doi:\n                        10.1007\/s10549-011-1872-9","journal-title":"Breast Cancer Res Treat"},{"key":"4331_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s13058-014-0427-5","volume":"16","author":"HA Azim Jr","year":"2014","unstructured":"Azim HA Jr, Partridge AH (2014) Biology of breast cancer in young women. Breast Cancer Res 16:427. doi:\n                        10.1186\/s13058-014-0427-5","journal-title":"Breast Cancer Res"},{"key":"4331_CR12","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1200\/JCO.2015.64.3536","volume":"34","author":"KC Aalders","year":"2016","unstructured":"Aalders KC, Postma EL, Strobbe LJ, van der Heiden-van der Loo M, Sonke GS, Boersma LJ, van Diest PJ, Siesling S, van Dalen T (2016) Contemporary locoregional recurrence rates in young patients with early-stage breast cancer. J Clin Oncol 34:2107\u20132114. doi:\n                        10.1200\/JCO.2015.64.3536","journal-title":"J Clin Oncol"},{"key":"4331_CR13","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/s0140-6736(00)02292-3","volume":"355","author":"S Aebi","year":"2000","unstructured":"Aebi S, Gelber S, Castiglione-Gertsch M, Gelber RD, Collins J, Thurlimann B, Rudenstam CM, Lindtner J, Crivellari D, Cortes-Funes H, Simoncini E, Werner ID, Coates AS, Goldhirsch A (2000) Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet 355:1869\u20131874. doi:\n                        10.1016\/s0140-6736(00)02292-3","journal-title":"Lancet"},{"key":"4331_CR14","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1200\/JCO.2006.10.3754","volume":"25","author":"SH Ahn","year":"2007","unstructured":"Ahn SH, Son BH, Kim SW, Kim SI, Jeong J, Ko SS, Han W (2007) Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea\u2014a report from the Korean Breast Cancer Society. J Clin Oncol 25:2360\u20132368. doi:\n                        10.1200\/JCO.2006.10.3754","journal-title":"J Clin Oncol"},{"key":"4331_CR15","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1200\/JCO.2011.36.1105","volume":"29","author":"ND Arvold","year":"2011","unstructured":"Arvold ND, Taghian AG, Niemierko A, Abi Raad RF, Sreedhara M, Nguyen PL, Bellon JR, Wong JS, Smith BL, Harris JR (2011) Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol 29:3885\u20133891. doi:\n                        10.1200\/JCO.2011.36.1105","journal-title":"J Clin Oncol"},{"key":"4331_CR16","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1200\/JCO.2012.44.1956","volume":"31","author":"AH Partridge","year":"2013","unstructured":"Partridge AH, Gelber S, Piccart-Gebhart MJ, Focant F, Scullion M, Holmes E, Winer EP, Gelber RD (2013) Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial. J Clin Oncol 31:2692\u20132698. doi:\n                        10.1200\/JCO.2012.44.1956","journal-title":"J Clin Oncol"},{"key":"4331_CR17","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1200\/JCO.2015.65.8013","volume":"34","author":"AH Partridge","year":"2016","unstructured":"Partridge AH, Hughes ME, Warner ET, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Tamimi RM (2016) Subtype-dependent relationship between young age at diagnosis and breast cancer survival. J Clin Oncol 34:3308\u20133314. doi:\n                        10.1200\/JCO.2015.65.8013","journal-title":"J Clin Oncol"},{"key":"4331_CR18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/oxfordjournals.jncimonographs.a003459","volume":"30","author":"A Goldhirsch","year":"2001","unstructured":"Goldhirsch A, Gelber RD, Yothers G, Gray RJ, Green S, Bryant J, Gelber S, Castiglione-Gertsch M, Coates AS (2001) Adjuvant therapy for very young women with breast cancer: need for tailored treatments. J Natl Cancer Inst Monogr 30:44\u201351","journal-title":"J Natl Cancer Inst Monogr"},{"key":"4331_CR19","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJMoa1412379","volume":"372","author":"PA Francis","year":"2015","unstructured":"Francis PA, Regan MM, Fleming GF, Lang I, Ciruelos E, Bellet M, Bonnefoi HR, Climent MA, Da Prada GA, Burstein HJ, Martino S, Davidson NE, Geyer CE Jr, Walley BA, Coleman R, Kerbrat P, Buchholz S, Ingle JN, Winer EP, Rabaglio-Poretti M, Maibach R, Ruepp B, Giobbie-Hurder A, Price KN, Colleoni M, Viale G, Coates AS, Goldhirsch A, Gelber RD (2015) Adjuvant ovarian suppression in premenopausal breast cancer. N Engl J Med 372:436\u2013446. doi:\n                        10.1056\/NEJMoa1412379","journal-title":"N Engl J Med"},{"key":"4331_CR20","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1200\/JCO.2015.64.3171","volume":"34","author":"MM Regan","year":"2016","unstructured":"Regan MM, Francis PA, Pagani O, Fleming GF, Walley BA, Viale G, Colleoni M, Lang I, Gomez HL, Tondini C, Pinotti G, Price KN, Coates AS, Goldhirsch A, Gelber RD (2016) Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer: TEXT and SOFT trials. J Clin Oncol 34:2221\u20132231. doi:\n                        10.1200\/JCO.2015.64.3171","journal-title":"J Clin Oncol"},{"key":"4331_CR21","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/annonc\/mdq072","volume":"21","author":"G Cancello","year":"2010","unstructured":"Cancello G, Maisonneuve P, Rotmensz N, Viale G, Mastropasqua MG, Pruneri G, Veronesi P, Torrisi R, Montagna E, Luini A, Intra M, Gentilini O, Ghisini R, Goldhirsch A, Colleoni M (2010) Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35\u00a0years) with operable breast cancer. Ann Oncol 21:1974\u20131981. doi:\n                        10.1093\/annonc\/mdq072","journal-title":"Ann Oncol"},{"key":"4331_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.7326\/M15-2886","volume":"164","author":"Siu AL, U. S. Preventive Services Task Force","year":"2016","unstructured":"Siu AL, U. S. Preventive Services Task Force (2016) Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 164:279\u2013296. doi:\n                        10.7326\/M15-2886","journal-title":"Ann Intern Med"},{"key":"4331_CR23","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1200\/JCO.2007.14.4287","volume":"26","author":"PL Nguyen","year":"2008","unstructured":"Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, Bellon JR, Wong JS, Smith BL, Harris JR (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26:2373\u20132378. doi:\n                        10.1200\/JCO.2007.14.4287","journal-title":"J Clin Oncol"},{"key":"4331_CR24","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.breast.2013.03.010","volume":"22","author":"J Brollo","year":"2013","unstructured":"Brollo J, Kneubil MC, Botteri E, Rotmensz N, Duso BA, Fumagalli L, Locatelli MA, Criscitiello C, Lohsiriwat V, Goldhirsch A, Leonardi MC, Orecchia R, Curigliano G (2013) Locoregional recurrence in patients with HER2 positive breast cancer. Breast 22:856\u2013862. doi:\n                        10.1016\/j.breast.2013.03.010","journal-title":"Breast"},{"key":"4331_CR25","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10549-011-1736-3","volume":"130","author":"HJ Kim","year":"2011","unstructured":"Kim HJ, Han W, Yi OV, Shin HC, Ahn SK, Koh BS, Moon HG, You JH, Son BH, Ahn SH, Noh DY (2011) Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive\/ER-negative subtype. Breast Cancer Res Treat 130:499\u2013505. doi:\n                        10.1007\/s10549-011-1736-3","journal-title":"Breast Cancer Res Treat"},{"key":"4331_CR26","doi-asserted-by":"publisher","first-page":"R70","DOI":"10.1186\/bcr1778","volume":"9","author":"van der Hage JA, Mieog JS, van de Vijver MJ, van de Velde CJ, European Organization for Research Treatment of Cancer","year":"2007","unstructured":"van der Hage JA, Mieog JS, van de Vijver MJ, van de Velde CJ, European Organization for Research Treatment of Cancer (2007) Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis. Breast Cancer Res 9:R70. doi:\n                        10.1186\/bcr1778","journal-title":"Breast Cancer Res"},{"key":"4331_CR27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/bmj.320.7233.474","volume":"320","author":"N Kroman","year":"2000","unstructured":"Kroman N, Jensen MB, Wohlfahrt J, Mouridsen HT, Andersen PK, Melbye M (2000) Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 320:474\u2013478","journal-title":"BMJ"},{"key":"4331_CR28","doi-asserted-by":"publisher","first-page":"484","DOI":"10.4143\/crt.2016.246","volume":"49","author":"SW Kim","year":"2017","unstructured":"Kim SW, Chun M, Han S, Jung YS, Choi JH, Kang SY, Yim H, Kang SH (2017) Young age is associated with increased locoregional recurrence in node-positive breast cancer with luminal subtypes. Cancer Res Treat 49:484\u2013493. doi:\n                        10.4143\/crt.2016.246","journal-title":"Cancer Res Treat"},{"key":"4331_CR29","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMoa0909638","volume":"362","author":"SM Swain","year":"2010","unstructured":"Swain SM, Jeong JH, Geyer CE Jr, Costantino JP, Pajon ER, Fehrenbacher L, Atkins JN, Polikoff J, Vogel VG, Erban JK, Rastogi P, Livingston RB, Perez EA, Mamounas EP, Land SR, Ganz PA, Wolmark N (2010) Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med 362:2053\u20132065. doi:\n                        10.1056\/NEJMoa0909638","journal-title":"N Engl J Med"},{"key":"4331_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1404037","volume":"371","author":"O Pagani","year":"2014","unstructured":"Pagani O, Regan MM, Walley BA, Fleming GF, Colleoni M, Lang I, Gomez HL, Tondini C, Burstein HJ, Perez EA, Ciruelos E, Stearns V, Bonnefoi HR, Martino S, Geyer CE Jr, Pinotti G, Puglisi F, Crivellari D, Ruhstaller T, Winer EP, Rabaglio-Poretti M, Maibach R, Ruepp B, Giobbie-Hurder A, Price KN, Bernhard J, Luo W, Ribi K, Viale G, Coates AS, Gelber RD, Goldhirsch A, Francis PA (2014) Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. N Engl J Med 371:107\u2013118. doi:\n                        10.1056\/NEJMoa1404037","journal-title":"N Engl J Med"},{"key":"4331_CR31","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.breast.2013.08.009","volume":"22","author":"MM Regan","year":"2013","unstructured":"Regan MM, Pagani O, Fleming GF, Walley BA, Price KN, Rabaglio M, Maibach R, Ruepp B, Coates AS, Goldhirsch A, Colleoni M, Gelber RD, Francis PA (2013) Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials. Breast 22:1094\u20131100. doi:\n                        10.1016\/j.breast.2013.08.009","journal-title":"Breast"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-017-4331-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4331-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4331-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T05:04:29Z","timestamp":1501736669000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-017-4331-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,10]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["4331"],"URL":"https:\/\/doi.org\/10.1007\/s10549-017-4331-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,10]]}}}